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g-Protein coupled receptor 18 
contributes to establishment of the 
cD8 effector T cell compartment
Hayakazu Sumida and Jason G. Cyster*
Department of Microbiology and Immunology, Howard Hughes Medical Institute, University of California, San Francisco, 
San Francisco, CA, United States
The requirements for effector and memory CD8 T cell development are incompletely 
understood. Recent work has revealed a role for G-protein coupled receptor 18 (GPR18) 
in establishment of the intestinal CD8αα intraepithelial lymphocyte compartment. Here, 
we report that GPR18 is also functionally expressed in conventional CD8αβ T  cells. 
When the receptor is lacking, mice develop fewer CD8+ KLRG1+ Granzyme B+ effector- 
memory cells. Bone marrow chimera studies show that the GPR18 requirement is CD8 
T cell intrinsic. GPR18 is not required for T-bet expression in KLRG1+ CD8 T cells. Gene 
transduction experiments confirm the functional activity of GPR18 in CD8 T  cells. In 
summary, we describe a novel GPCR requirement for establishment or maintenance of 
the CD8 KLRG1+ effector-memory T cell compartment. These findings have implications 
for methods to augment CD8 effector cell numbers.
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inTrODUcTiOn
CD8 T  cells that have responded to antigenic stimuli have been classically divided into CD44hi 
CD62Llo effector memory (EM) and CD44hi CD62Lhi central memory (CM) cells (1). Early studies 
on the CD8 T  cell response following lymphocytic choriomeningitis virus (LCMV) and Listeria 
infection showed that CD8 T cells expand and differentiate through an early effector cell (EEC) stage 
into distinct effector populations, including short-lived effector cells (SLEC) and memory precursor 
effector cells (MPEC) (2, 3). SLECs are distinguished by high expression of KLRG1 and low expres-
sion of the IL7Rα chain (CD127), while MPEC have the reciprocal marker pattern (4, 5). Both types 
of cell express effector molecules such as Granzyme B and IFNγ, but only MPECs are efficient at 
giving rise to memory responses. Subsequent studies in a number of systems have shown a less clear 
correlation between expression of KLRG1 and a short-lived effector state. In some cases, the KLRG1+ 
cells persisted to the memory phase and provided effective control of the infection despite weak 
recall proliferative responses (6, 7). Other studies have noted that the amount of KLRG1 expressed 
by the effector-memory population may be determined by the amount of exposure to inflammatory 
signals during CD8 cell differentiation (8, 9). While all the factors responsible for determining the 
size of the KLRG1+ effector-memory population have not been defined, it has been established that 
the size of this compartment can be promoted by the pro-survival activity of IL-15 and restricted by 
the proapoptotic effect of TGFβ (4, 10). Several studies have shown a role for high expression of the 
transcription factor T-bet in establishing the KLRG1+ effector cell compartment (11–13).
The G-protein coupled receptor G-protein coupled receptor 18 (GPR18) is abundantly expressed in 
lymphocytes, with particularly high expression in CD8αα γδT intraepithelial lymphocytes (IELs) (14). 
Two recent studies using independently generated GPR18-deficient mouse lines found that this 
receptor plays a role in establishing an IEL compartment of normal size (14, 15). However, whether 
this receptor has functions in conventional T cells has been unknown.
FigUre 1 | Reduction of KLRG1+ CD8 EM T cells in G-protein-coupled receptor 18 (GPR18)-deficient peripheral blood lymphocytes (PBL). (a) Gpr18 transcript 
abundance in the indicated cell subsets relative to Hprt. Each point indicates cells sorted from an individual mouse and lines indicate mean ± SEM. n = 3 or 4 in 
each populations. EM, effector-memory; CM, central memory; IEL, intraepithelial lymphocytes. (B) Flow cytometric analysis of CD44 and CD62L expression in CD8+ 
TCRβ+ PBL from the indicated mature (6 months old) mice. Numbers show percentage of cells in the indicated gate. (c) Frequency of EM (CD44hi CD62Llo), CM 
(CD44hi CD62Lhi), and naive (CD44lo CD62Lhi) CD8+ or CD4+ TCRβ+ cells in PBL from young (2 months old, left panel) or mature (6 months old, right panel) 
Gpr18+/−and Gpr18−/− mice. Left panel: Gpr18+/−, n = 8; Gpr18−/−, n = 8. Right panel: Gpr18+/−, n = 21; Gpr18−/−, n = 16. (D) Flow cytometric analysis of KLRG1 
expression in CD8 EM PBL from the indicated mature (6 months old) mice. Numbers show percentage of cells in the indicated gate. (e) Frequency of KLRG1+ CD8 
EM PBL in indicated young (2 months old) or mature (6 months old) mice. Young adults: Gpr18+/−, n = 8; Gpr18−/−, n = 8. Mature adults: Gpr18+/−, n = 21; Gpr18−/−, 
n = 16. Each point represents data from an individual mouse and lines represent means ± SEM (c,e). ***p < 0.001, **p < 0.01, *p < 0.05, “n.s.” p > 0.05 by 
Student’s t-test (c,e).
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In the course of our work to characterize how GPR18 contrib-
utes to IEL function, we noticed that GPR18-deficient mice had 
a lower frequency of CD44hi CD62Llo effector-memory type CD8 
T cells. Here, we have characterized this deficiency and find that 
GPR18 knockout (KO) mice have lower numbers of spontane-
ously forming KLRG1+ CD8 effector-memory cells.
MaTerials anD MeThODs
Mice, reagents, and infection
C57BL/6J (B6, CD45.2) and congenic B6 CD45.1+ mice were 
from the Jackson Laboratory, and these strains were intercrossed 
to generate B6 CD45.1/2 F1 mice. Gpr18−/− mice were generated as 
FigUre 2 | Continued
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FigUre 2 | Reduction of KLRG1+ CD8 effector memory (EM) T cells in lymphoid tissues of G-protein coupled receptor 18 (GPR18)-deficient naïve mice  
(a) Frequency of EM (CD44hi CD62Llo), central memory (CM) (CD44hi CD62Lhi), and naive (CD44lo CD62Lhi) populations in CD8+ or CD4+ TCRβ+ splenocytes in 
mature mice (6 months old) of the indicated type. Gpr18+/−, n = 11; Gpr18−/−, n = 12. (B) Number of CD8+ TCR β+ splenocytes in the indicated mature (6 months 
old) mice. Each population was pre-gated on CD45+TCRβ+ cells. Gpr18+/−, n = 13; Gpr18−/−, n = 14. (c) Frequency of KLRG1+ cells in CD8 EM splenocytes in 
indicated mature (6 months old) mice. Gpr18+/−, n = 9; Gpr18−/−, n = 8. (D) Numbers of KLRG1+ CD8 EM splenocytes in indicated mature (6 months old) mice. 
Gpr18+/−, n = 8; Gpr18−/−, n = 8. (e) Frequency of EM, CM, and naive populations in CD8+ or CD4+ TCRβ+ lymphocytes from mesenteric lymph nodes (mLN) in 
indicated mature (6 months old) mice. Gpr18+/−, n = 7; Gpr18−/−, n = 6. (F) Frequency of KLRG1+ populations in CD8 EM from mLN in indicated mature (6 months 
old) mice. Gpr18+/−, n = 8; Gpr18−/−, n = 7. (g) Percentages of Gpr18−/− or control Gpr18−/− EM cells in gp33 tetramer+ CD8 T cells in peripheral blood lymphocytes 
(PBL) at day 8 and day 30 after lymphocytic choriomeningitis virus (LCMV) Armstrong infection. (h) Percentages of early effector cell (EEC) (KLRG1lo CD127lo), 
memory precursor effector cells (MPEC) (KLRG1lo CD127hi), and short-lived effector cells (SLEC) (KLRG1hi CD127lo) in gp33 tetramer+ CD44hi CD8 PBL at day 8  
and day 30 after LCMV Armstrong infection. (g,h) Gpr18+/−, n = 4; Gpr18−/−, n = 5. Each point represents data from an individual mouse and lines represent 
means ± SEM (a–h). ***p < 0.001, **p < 0.01, *p < 0.05, “n.s.” p > 0.05 by Student’s t-test.
4
Sumida and Cyster GPR18 functions in CD8 Cells
Frontiers in Immunology | www.frontiersin.org April 2018 | Volume 9 | Article 660
described (14) To generate bone marrow (BM) chimeras, CD45.1+ 
B6 mice were irradiated by exposure to 1,100 rad of γ-irradiation 
in two doses 5 h apart and i.v. injected with at least 2 × 106 total 
BM cells from each genotype of mice as indicated and analyzed 
after 2–3 months. All chimeras appeared healthy at the time of 
analysis. For LCMV infection, mice were infected with 2 ×  105 
plaque-forming units of LCMV Armstrong administered i.v. 
Animals were housed in a specific pathogen-free environment in 
the Laboratory Animal Research Center at the UCSF, and all exp-
eriments conformed to ethical principles and guidelines approved 
by the UCSF Institutional Animal Care and Use Committee.
cell Preparations
For peripheral blood lymphocytes (PBL) preparation, blood was 
collected into EDTA-coated tubes and red cell lysis was per-
formed. Splenocyte and mesenteric lymph node cell suspensions 
were prepared by mashing the organs through 70-µm cell strain-
ers and then suspended with RPMI-1640 medium supplemented 
with 5% FCS.
antibodies and Flow cytometry
Cells were stained using standard procedures for surface markers. 
The following monoclonal antibodies were used for flow cytome- 
try: TCRβ (H57; BioLegend), CD4 (GK1.5; BioLegend), CD8α 
(53.6.7; Tonbo Bio), CD8β (H35; eBioscience), CD45.1 (A20; 
BioLegend), CD45.2 (104; BioLegend), CD62L (MEL-14; 
BioLegend), CD44 (IM7; BD), KLRG1 (2F1/KLRG1; BioLegend), 
CD127 (A7R34; eBioscience), CXCR3 (CXCR3-173; BioLegend), 
IFNγ (XMG1.2; BD), Granzyme B (GB11; Invitrogen), Ki-67 (B56; 
BD), and T-bet (4B10; BioLegend). For cell sorting, dead cells were 
excluded using Fixable Viability Dye eFluor780 (eBioscience) 
and sorted splenocytes were more than 95% pure. For intracel-
lular Granzyme B or T-bet staining, harvested cells were stained 
for surface markers then fixed and permeabilized with Cytofix/
Cytoperm (BD) or Intracellular Fixation and Permeabilization 
Buffer Set (eBioscience), respectively. For intracellular IFN-γ stain-
ing, harvested splenocytes were stimulated with 100 ng/ml phorbol 
myristate acetate (PMA) and 1 µg/ml ionomycin for 4–5 h in the 
presence of GolgiPlug (Brefeldin A, BD). After culture, cells were 
stained for surface markers then fixed and permeabilized with 
Cytofix/Cytoperm (BD) and stained for intracellular cytokines. 
Flow cytometric analysis was performed using a BD LSRII. Sorting 
was with a BD Aria instrument. Flow cytometry data were pro-
cessed using FlowJo version 10.2 software (Tree Star).
Quantitative rT-Pcr
Total RNA from sorted cells was extracted using an RNeasy 
kit (Qiagen) and reverse-transcribed. Quantitative PCR was 
performed as described (16). Data were analyzed using the 
comparative CT (2−ΔΔCt) method using Hprt as the reference. The 
primers were as follows:
Hprt: sense primer, 5′-AGGTTGCAAGCTTGCTGGT-3′ and 
antisense primer, 5′-TGAAGTACTCATTATAGTCAAG 
GGCA-3′.
Gpr18: sense primer, 5′-CTCTCTCTGGGACTGGGCAG-3′ and 
antisense primer, 5′-GGTGGCCATCTTACAGCAGG-3′.
retroviral BM Transduction
Gpr18−/− (CD45.2+CD45.1−) cells were retrovirally transduced 
with MSCV2.2 retroviral vectors containing GPR18 or empty 
vector and an IRES–GFP reporter as described previously (17). 
Virus was produced using PlatE cells grown in DMEM + 10% 
FCS +  P/S +  10  mM HEPES +  Q(Glu) (without P/S during 
transfection). BM cells were harvested 4 days after 5-flurouracil 
(Sigma) injection and cultured in the presence of recombinant 
IL-3, IL-6, and mouse stem cell factor (100 ng/ml, Peprotech). 
BM  cells were spin-infected twice with a retroviral construct 
expressing GPR18 or empty vector and an IRES–GFP cassette as 
a reporter. One day after the last spin infection, cells were injected 
into lethally irradiated CD45.2−CD45.1+ B6 recipients.
intravascular staining
A total of 3  µg anti-CD8α-PE (clone 53-6.7 from Biolegend) 
antibody was injected i.v. At 3 min after injection, the animals 
were sacrificed and analyzed as described (18).
statistical analysis
Prism (GraphPad, ver. 5.0a) software was used for all statistical 
analyses. Two-tailed, unpaired Student’s t-tests were performed 
when comparing two groups. p-Values less than 0.05 were consid-
ered significant. In graphs, horizontal lines indicate means, and 
error bars indicate SEM.
resUlTs
Analysis of GPR18 transcript expression in T cell subsets con-
firmed the high expression in CD8αα IELs and revealed consid-
erable expression in CD8 T  cells and slightly lower expression 
FigUre 3 | Continued
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FigUre 3 | Cell intrinsic defects of KLRG1+ CD8 T cells in G-protein coupled receptor 18 (GPR18)-deficiency. B6-CD45.1+ mice were reconstituted with CD45.1/2+ 
WT and CD45.2+ Gpr18+/− or Gpr18−/− bone marrow (BM) 10 weeks before analysis (n = 6). (a) Flow cytometric analysis of CD44 and CD62L expression in CD8+ 
TCRβ+ and congenic (CD45) marker+ splenocytes from the indicated donor cells in the same animal. Numbers show percentage of cells in the indicated gate.  
(B) Naïve (CD44loCD62Lhi), effector memory (EM) (CD44hiCD62Llo), and CM (CD44hiCD62Lhi) T cells in Gpr18+/− or Gpr18−/− CD8+ TCRβ+ cells, identified as in (A), 
were presented as a ratio to the WT control donor cells from the same animal in peripheral blood lymphocytes (PBL) (upper panel) or spleen (lower panel). (c) Flow 
cytometric analysis of KLRG1 expression in CD8 EM splenocytes from the indicated donor cells in the same animal. (D) Percentage of KLRG1+ cells in Gpr18+/− or 
Gpr18−/− CD8+ EM TCRβ+ cells, determined as in (c), presented as a ratio to the WT control donor cells from the same animal in PBL (upper panel) or spleen (lower 
panel). Each symbol in (B,D) represents an individual mouse, and lines represent means ± SEM. *p < 0.05 by Student’s t-test (B,D). Data from one of two or three 
independent experiments are shown.
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in CD4 T cells (Figure 1A). Expression was retained in CD44hi 
CD62Llo EM and CD44hi CD62Lhi CM CD8 T cells. Flow cyto-
metric analysis of CD44hi CD62Llo EM CD8 T cell frequencies 
in blood revealed a slight reduction in young (2-month-old 
mice) and a significant reduction in mature (6-month old) 
GPR18-deficient mice (Figures 1B,C). The frequencies of blood 
CD4 T cells and of naïve and CM CD8 T cells were unaltered in 
GPR18-deficient mice (Figure 1C; Figure S1A in Supplementary 
Material). Examination of marker expression within the CD8 EM 
compartment revealed a strong deficiency in KLRG1+ cells in the 
GPR18 KO mice (Figures 1D,E). Given that exposure to com-
mensal and environmental antigens may differ between mouse 
cages, our studies were done with co-cocaged littermate mice 
generated in heterozygote by KO intercrosses. We do not exclude 
the possibility that GPR18 heterozygosity causes a partial effect 
on the CD8 compartment that may cause us to underestimate the 
magnitude of the KO phenotype.
The reduction in CD8 EM cells, but not CD4 EM cells, was also 
observed in the spleen of mature-aged mice (Figure 2A; Figure 
S1B in Supplementary Material). Enumeration of total spleen cells 
established that there was an overall deficiency in EM CD8 T cells 
(Figure  2B). Staining for KLRG1 confirmed the selective defi-
ciency of KLRG1+ cells amongst CD8 EM cells (Figures 2C,D). 
A deficiency in KLRG1+ CD8 EM cells was also observable in 
mesenteric LNs (Figures  2E,F). Regarding GPR18 expression, 
KLRG1+ and KLRG1− CD8 EM cells showed comparable mRNA 
levels (Figure 1A).
The KLRG1+ CD8 EM cells studied above were those arising 
endogenously in mice housed in our specific pathogen-free mouse 
facility. To test whether GPR18 was involved in the generation of 
KLRG1-expressing cells that appear rapidly following viral infec- 
tion, GPR18 KO and control mice were infected with LCMV 
Armstrong and examined after 8 and 30 days. Gating on LCMV-
specific gp33-tetramer+ CD8 T cells revealed an equivalent percent-
age of EM cells in control and GPR18 KO mice (Figure 2G; Figure S2 
in Supplementary Material). Gating on total CD44hi gp33-tetramer+ 
cells showed an equivalent fraction of these cells were KLRG1+ 
CD127lo SLEC not only at day 8 but also at day 30, when the LCMV 
response is in the effector or effector-memory stage (Figure 2H; 
Figure S2 in Supplementary Material). These findings indicate that 
the influence of GPR18 on establishment of a KLRG1+ CD8 cell 
compartment varies depending on the induction conditions.
To determine if the reduction in CD8 EM reflected a cell 
intrinsic role for GPR18, we generated mixed BM chimeras. 
Analysis of these mice 10 weeks after reconstitution revealed a 
selective deficiency in GPR18 KO EM cells in blood and spleen 
(Figures 3A,B). The effect was again most prominent for KLRG1+ 
CD8 EM cells (Figures 3C,D). These data indicate that the GPR18 
receptor acts intrinsically to favor establishment or maintenance 
of the KLRG1+ CD8 EM compartment.
To rule out that the reduction in CD8 EM cells was due to 
selective loss of the KLRG1 surface marker, we stained CD8 T cells 
in mixed BM chimeras for Granzyme B, since this gene is highly 
expressed in KLRG1+ cells (2, 3). The frequency of Granzyme B+ 
cells was reduced in GPR18 KO CD8 EM to an extent similar 
to the reduction in KLRG1+ cells (Figure  4A, left panel and 
Figure 3A; Figure S3A in Supplementary Material). When gating 
on the KLRG1+ population, the fraction of Granzyme B+ cells 
was not altered, in accord with a reduction in population size 
rather than selective changes in marker expression (Figure 4A 
right panel; Figure S3B in Supplementary Material). Since T-bet 
(Tbx21) is needed for KLRG1+ CD8 EM cell development, we 
tested whether its expression was affected by GPR18 deficiency. 
Intracellular flow cytometry showed similar expression in 
the KLRG1+ CD8 cells that were present in GPR18 KO mice 
compared to those present in matched controls (Figures 4B,C). 
Indeed, rather than being reduced, a non-statistically significant 
trend for increased T-bet expression was observed. T-bet expres-
sion levels in KLRG1− cells were lower than in KLRG1+ cells as 
expected and were equivalent in KO and control (Figures 4B,C). 
These data indicate that GPR18 is not required for upregulation 
of the T-bet transcription factor in CD8 EM cells.
CXCR3 affects the balance between effector and memory CD8 
T-cell generation (19), and we, therefore, investigated expression 
levels of this chemokine receptor. CXCR3 was expressed compara-
bly in GPR18 KO and wild-type CD8 T cells (Figure 4D). Further 
analysis of the mixed BM chimeras showed that the fraction of 
cells that were in or had recently been in cell cycle, as determined 
by Ki-67 staining, was unaltered by GPR18-deficiency (Figure 4E; 
Figures S4A,B in Supplementary Material). IFNγ staining showed 
that expression of this cytokine in CD8 cells was not affected by 
GPR18 deficiency (Figure S5 in Supplementary Material).
Since KLRG1+ and KLRG1− effector-memory cells differ in 
their distribution within the spleen, with KLRG1+ cells locat-
ing predominantly in the highly vascular red pulp (9, 20), we 
tested for any effect of GPR18 deficiency on cell distribution 
using in  vivo CD8α-PE labeling. This technique labels cells 
that are in blood-exposed compartments such as the red pulp 
while leaving cells in the lymphoid-rich white pulp unlabeled 
(18, 21). As expected, KLRG1− cells were predominantly pro- 
tected from labeling, being enriched in the white pulp, while 
KLRG1+ cells were highly labeled (Figure 4F). GPR18-deficiency 
FigUre 4 | Continued
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FigUre 5 | Rescue effects of G-protein-coupled receptor 18 (GPR18) expression on CD8 effector memory (EM) cells in Gpr18−/− mice. (a,B) CD45.2+ Gpr18−/− 
bone marrow transduced with empty vector or Gpr18 retrovirus was used to reconstitute CD45.1+ recipients (n = 5). Donor cells were gated on CD45.1−CD45.2+ 
and then gated on GFP+ (transduced donor cells) or GFP− (untransduced donor cells). (a) CD8+ TCRβ+ cells from peripheral blood lymphocytes (PBL) (left panel) or 
spleen (right panel) were stained for naïve (CD44loCD62Lhi), EM (CD44hiCD62Llo), and CM (CD44hiCD62Lhi). Percentage of EM, CM, and naïve populations in GFP+ 
donor cells were presented as a ratio to those in GFP− donor cells from the same animal. (B) CD8 EM cells from PBL (left panel) or spleen (right panel) were stained 
for KLRG1. Percentage of KLRG1+ populations in GFP+ donor cells were presented as a ratio to those in GFP− donor cells from the same animal. Each symbol 
represents an individual mouse, and lines represent means ± SEM. ***p < 0.001, **p < 0.01, *p < 0.05 by Student’s t-test.
FigUre 4 | Granzyme B, T-bet, CXCR3, and Ki67 expression in Gpr18−/− CD8 effector memory (EM) cells. (a) Intracellular staining of splenic CD8 EM (left panel) or 
KLRG1+ (right panel) cells for Granzyme B. Data are plotted as ratio of Granzyme B+ Gpr18+/− or Gpr18−/− cells and WT cells in the same mixed bone marrow (BM) 
chimeric animal. (B) Representative histograms of T-bet staining in KLRG1+ (left panels) or KLRG1− (right panels) CD8 EM splenocytes. Upper panels, stained with 
isotype control antibodies, middle and lower panels stained with T-bet antibodies. Cells were from mixed BM chimeras of the indicated types. y-axis of histogram 
overlays was normalized to mode. (c) Mean fluorescence intensity (MFI) of T-bet staining in KLRG1+ or KLRG1− CD8 EM splenocytes, plotted as ratio of MFI in 
Gpr18+/− or Gpr18−/− compared to control WT in mixed BM chimeras (n = 6). (D) Flow cytometry analysis of CXCR3 expression in KLRG1+ and KLRG1− CD8 EM 
cells from mixed BM chimeras. Upper panel; histograms from Gpr18+/− plus WT mixed BM chimera. Lower panel; histograms from Gpr18−/− plus WT mixed BM 
chimera. y-axis of histogram overlays was normalized to mode. (e) Ratio of percentage of Ki67+ CD8 EM or KLRG1+ CD8 EM cells in Gpr18+/− or Gpr18−/− 
compared to control WT in mixed BM chimeras (n = 6). (F) In vivo labeling with CD8α-PE antibody. Three minutes after antibody injection into the indicated mice, 
splenocytes were harvested and stained ex vivo with antibodies to identify KLRG1+ or KLRG1− CD8 EM cells. Representative plots gated on KLRG1+ (upper panels) 
and KLRG1− (lower panels) are shown. Numbers show percentage of cells in indicated CD8α-PE+ gate. Each symbol in (a,c,e) represents an individual mouse, and 
lines represent means ± SEM. *p < 0.05, “n.s.” p > 0.05 by Student’s t-test (a,c,e). Data from one of two independent experiments are shown.
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did not affect the fraction of KLRG1− or KLRG1+ cells that were 
labeled, indicating that the cells were located in their correct 
compartments.
Finally, to confirm that the phenotype observed was solely 
due to GPR18 deficiency, we restored GPR18 expression by 
transduction of GPR18 KO BM  cells with a GPR18 and GFP 
encoding retrovirus, versus a GFP control retrovirus (empty 
vector). Irradiated mice were reconstituted with the transduced 
BM cells and then analyzed for the frequency of each CD8 cell 
type that was transduced (GFP+) versus untransduced (GFP−) 
to test for enrichment or depletion of the transduced cells. 
Compared to mice reconstituted with GPR18 KO BM transduced 
with the empty vector, mice receiving GPR18 KO BM transduced 
with GPR18 showed a selective increase in transduced CD8 EM 
and KLRG1+ cells in blood and spleen (Figures 5A,B; Figures 
S6A,B in Supplementary Material). These data provide strong 
9Sumida and Cyster GPR18 functions in CD8 Cells
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support for the conclusion that the altered CD8 T cell compart-
ments in the GPR18-deficient mice reflects a direct requirement 
for GPR18.
DiscUssiOn
Our findings establish a cell intrinsic role for GPR18 in the 
normal accumulation of CD8 effector T cells, in particular, the 
KLRG1+ EM cell population. The CD8 effector cells studied here 
are those arising endogenously over time in mice housed in a 
specific pathogen-free colony. In experiments where we infected 
mice with the pathogen LCMV (Armstrong strain), we did 
not detect clear differences in the induced EM cell populations 
between GPR18 KO and littermate control mice. Further studies 
will be needed to define the types of response where GPR18 con-
tributes to KLRG1+ CD8 EM cell development or maintenance, 
but at this time, we suggest the receptor is influencing their devel-
opment in response to commensal microorganisms. Two ligands 
have been proposed for GPR18, N-arachidonyl glycine (NAGly), 
and resolvin-D2 (22–24). In our previous work and studies by 
others, NAGly has not been confirmed to be a functional GPR18 
agonist (14, 25). Future studies will be needed to determine 
whether resolvin-D2 or an as yet unidentified GPR18 ligand acts 
to promote effector CD8 T cell homeostasis. Our studies suggest 
that small molecule agonists of GPR18 might augment the size 
of the KLRG1+ effector CD8 T cell compartment, an effect that 
might be beneficial, for example, during viral responses or in the 
context of tumor immunotherapy. Our findings may also prove 
significant for understanding the GPR18 SNPs detected as being 
enriched in inflammatory bowel disease patients in genome-wide 
association studies (26, 27).
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FigUre s1 | Comparable CD4 T cells in G-protein-coupled receptor 18 
(GPR18)-deficient mice. (a) Flow cytometric analysis of CD44 and CD62L 
expression in CD4+ TCRβ+ peripheral blood lymphocytes (PBL) from the 
indicated mature (6 months old) mice. Numbers show percentage of cells in the 
indicated gate. (B) Number of CD4+ TCR β+ splenocytes in the indicated mature 
(6 months old) mice. Each population was pre-gated on CD45+TCRβ+ cells. 
Gpr18+/−, n = 12; Gpr18−/−, n = 12.
FigUre s2 | Comparable CD8 effector memory and short-lived effector cells 
(SLEC) in Gpr18−/− mice after infection with lymphocytic choriomeningitis virus 
(LCMV) Armstrong. Representative flow cytometric plots and gating strategy for 
Figures 2g,h. peripheral blood lymphocytes (PBL) from Gpr18+/− (upper panels) 
or Gpr18−/− (lower panels) at day 30 after LCMV Armstrong infection.
FigUre s3 | Granzyme B expression in CD8 effector memory (EM) and KLRG1+ 
cells in Gpr18−/− mice. (a,B) Representative flow cytometric plots for Figure 4a 
for splenocytes from the indicated donor cells in the same animal [Gpr18+/− (left) 
or Gpr18−/− (right) compared to control WT in mixed bone marrow (BM) 
chimeras]. (a) CD8 EM cells and (B) short-lived effector cells (SLEC). Numbers 
show percentage of cells in the indicated gate.
FigUre s4 | Comparable percentage of Ki-67+ CD8 effector memory (EM) or 
short-lived effector cells in Gpr18−/− mice. (a,B) Representative flow cytometric 
plots for Figure 4c for splenocytes from the indicated donor cells in the same 
animal [Gpr18+/− (left) or Gpr18−/− (right) compared to control WT in mixed bone 
marrow (BM) chimeras]. (a) CD8 EM cells and (B) KLRG1+ cells. Numbers show 
percentage of cells in the indicated gate.
FigUre s5 | Comparable IFN-γ production in Gpr18−/− and control CD8 T cells. 
Intracellular staining of CD8 effector memory (EM) splenocytes for IFN-γ, shown 
as percentage of IFN-γ producing cells from Gpr18+/− or Gpr18−/− mice after 5 h 
in vitro stimulation with phorbol myristate acetate plus ionomycin. Gpr18+/−, 
n = 4; Gpr18−/−, n = 5. Combined data from two independent experiments are 
shown.
FigUre s6 | Rescue effect of G-protein coupled receptor 18 (GPR18) 
expression on CD8 effector memory (EM) and KLRG1+ cells in Gpr18−/− mice. 
(a,B) Gating strategy for Figure 5 for peripheral blood lymphocytes (PBL) from 
empty vector-transduced GPR18−/− bone marrow (BM) chimera mice (a) or 
GPR18-transduced GPR18−/− BM chimera mice (B). Numbers show percentage 
of cells in the indicated gate.
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